Skip NavigationSkip to Content

The mutagenic effects of 7,12-dimethylbenz[a]anthacene, 3-methylcholanthrene and benzo[a]pyrene to the developing Syrian hamster fetus measured by an in vivo/in vitro mutation assay

  1. Author:
    Donovan, P. J.
    Smith, G. T.
    Nardone, R.
  2. Author Address

    NCI, Lab Comparat Carinogenesis, Ft Detrick, MD 21702 USA. Catholic Univ Amer, Biol Dept, Washington, DC 20064 USA Donovan, PJ, NCI, Lab Comparat Carinogenesis, Bldg 538,Room 205E, Ft Detrick, MD 21702 USA
    1. Year: 2004
    2. Date: OCT 4
  1. Journal: Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis
    1. 554
    2. 1-2
    3. Pages: 111-120
  2. Type of Article: Article
  1. Abstract:

    The transplacental mutagenicity of three polycylic aromatic hydrocarbons, 7,12-dimethylbenz[a]anthacene (DMBA), 3-methylcholanthrene (MC) and benzo[a]pyrene (BP), was measured by an in vivo/in vitro mutation assay. Fetal sensitivity and dose-response characteristics with regard to transplacental mutagenesis by these compounds have never been quantified. In the current experiment, pregnant Syrian hamsters were exposed to these compounds at day 12 of gestation. Twenty-four hours later the fetuses were removed and their cells were allowed a 5-day expression time in culture. They were then seeded for colony formation and also for mutation selection by diphtheria toxin. DMBA at 0.2 mmol/kg (51.3 mg/kg) had an induced mutant frequency of 1.56 x 10(-4) Mutants per surviving cell. This was 598 times the historical control. DMBA at 0.2 mmol/kg was 3.6 times more potent than the highly mutagenic positive control, ethylnitrosourea, at 1 mmol/kg. DMBA also caused a dose-dependent increase in cloning efficiency, which was highly correlated with mutation rate. BP and MC were less effective than DMBA, causing increased mutations that were 31.6 and 17.7 times the historical control, respectively, and for neither was there any correlation of mutation rate with cloning efficiency. The special effectiveness of DMBA as a transplacental mutagen may relate to its ability to cause increased cell division and fixation of DNA lesions as mutations. (C) 2004 Elsevier B.V. All rights reserved

    See More

External Sources

  1. DOI: 10.1016/j.mrfmmm.2004.04.003
  2. WOS: 000223821800012

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel